Glucose transporters and transport kinetics in retinoic acid-differentiated T47D human breast cancer cells.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  American Journal of Physiology. Endocrinology and Metabolism

• Publication date

  2000-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1152/ajpendo.2000.279.3.e508PMID 10950817
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Regulation Of Carbohydrate Metabolism

  2018cited by this paper
• An immunohistochemical study

  2013cited by this paper
• Role for glucose transporter 1 protein in human breast cancer

  2008cited by this paper
• Rapid Activation of GLUT- 1 Glucose Transporter following Inhibition of Oxidative Phosphorylation in Clone 9 Cells*

  2001cited by this paper
• Glut-1 and hexokinase expression: relationship with 2-fluoro-2-deoxy-D-glucose uptake in A431 and T47D cells in culture.

  1999cited by this paper
• Kinetics of cyclocreatine and Na(+) cotransport in human breast cancer cells: mechanism of activity.

  1999cited by this paper
• Kinetics of cyclocreatine and Na+ cotransport in human breast cancer cells: mechanism of activity.

  1999cited by this paper
• Enhancement of ATP Levels and Glucose Metabolism during an Infection by Chlamydia

  1998cited by this paper
• Effects of ALL‐trans‐retinoic acid and 13‐cis‐retinoic acid on breast‐cancer cell lines: Growth inhibition and apoptosis induction

  1997cited by this paper
• Immunohistochemical detection of glut 3 in human tumors and normal tissues

  1997cited by this paper
• Expression of glucose transporters in human pancreatic tumors compared with increased FDG accumulation in PET study.

  1997cited by this paper
• Immunohistochemical detection of Glut3 in human tumors and normal tissues.

  1997cited by this paper
• Deregulated simultaneous expression of multiple glucose transporter isoforms in malignant cells and tissues.

  1997cited by this paper
• Differential effects of retinoids and antiestrogens on cell cycle progression and cell cycle regulatory genes in human breast cancer cells.

  1996cited by this paper
• Upregulation of cytokeratins 8 and 18 in human breast cancer T47D cells is retinoid-specific and retinoic acid receptor-dependent.

  1996cited by this paper
• 2-Deoxyglucose transport and metabolism in Caco-2 cells.

  1996influential reference
• Translocation of GLUT1 Does Not Account for Elevated Glucose Transport in Glucose-deprived 3T3-L1 Adipocytes (*)

  1996cited by this paper
• Expression of the fructose transporter GLUT5 in human breast cancer.

  1996influential reference
• Intratumoral distribution of tritiated-FDG in breast carcinoma: correlation between Glut-1 expression and FDG uptake.

  1996cited by this paper
• Variations in energy and phospholipid metabolism in normal and cancer human mammary epithelial cells.

  1996cited by this paper
• Wide expression of the human erythrocyte glucose transporter Glut1 in human cancers.

  1996influential reference
• Kinetics of choline transport and phosphorylation in human breast cancer cells; NMR application of the zero trans method.

  1996cited by this paper
• Retinoic acid receptor beta mediates the growth-inhibitory effect of retinoic acid by promoting apoptosis in human breast cancer cells

  1996cited by this paper
• Expression of retinoic acid receptor beta mediates retinoic acid-induced growth arrest and apoptosis in breast cancer cells.

  1995cited by this paper
• GLUT1 expression in human breast carcinoma: correlation with known prognostic markers.

  1995cited by this paper
• Chapter 10 – Carbohydrate Metabolism and Neoplasia: New Perspectives for Diagnosis and Therapy

  1994cited by this paper
• The retinoid receptors.

  1994cited by this paper
• Breast Cancer: Spectroscopy and Imaging of Cells and Tumors

  1994cited by this paper
• The retinoid receptors.

  1994cited by this paper
• Rapid activation of GLUT-1 glucose transporter following inhibition of oxidative phosphorylation in clone 9 cells.

  1993cited by this paper
• Facilitated glucose transporters in epithelial cells.

  1993cited by this paper
• Deviant energetic metabolism of glycolytic cancer cells.

  1992cited by this paper
• Tamoxifen induced changes in MCF7 human breast cancer: in vitro and in vivo studies using nuclear magnetic resonance spectroscopy and imaging.

  1992cited by this paper
• Mammalian facilitative glucose transporter family: structure and molecular regulation.

  1992influential reference
• Mammalian glucose transporters: structure and molecular regulation.

  1991cited by this paper
• Facilitated diffusion of glucose.

  1990cited by this paper
• Over-expression of facilitative glucose transporter genes in human cancer.

  1990cited by this paper
• Effects of 2-deoxyglucose on drug-sensitive and drug-resistant human breast cancer cells: toxicity and magnetic resonance spectroscopy studies of metabolism.

  1990influential reference
• Metabolic studies of estrogen- and tamoxifen-treated human breast cancer cells by nuclear magnetic resonance spectroscopy.

  1989cited by this paper
• Kinetics of transport: analyzing, testing, and characterizing models using kinetic approaches.

  1989influential reference
• Glucose metabolism in drug-sensitive and drug-resistant human breast cancer cells monitored by magnetic resonance spectroscopy.

  1988cited by this paper
• Transformation of rat fibroblasts by FSV rapidly increases glucose transporter gene transcription.

  1987cited by this paper
• Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes.

  1987cited by this paper
• The effects of retinoid treatment and antiestrogens on the growth of T47D human breast cancer cells.

  1986cited by this paper
• Monitoring the time course of cerebral deoxyglucose metabolism by 31P nuclear magnetic resonance spectroscopy.

  1985cited by this paper
• Cellular biology and biochem-istry of the retinoids

  1984cited by this paper
• Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cells.

  1980cited by this paper
• The roles of transport and phosphorylation in nutrient uptake in cultured animal cells.

  1980cited by this paper
• Loss of radioactive 2-deoxy-D-glucose-6-phosphate from brains of conscious rats: implications for quantitative autoradiographic determination of regional glucose utilization.

  1978cited by this paper
• THE [14C]DEOXYGLUCOSE METHOD FOR THE MEASUREMENT OF LOCAL CEREBRAL GLUCOSE UTILIZATION: THEORY, PROCEDURE, AND NORMAL VALUES IN THE CONSCIOUS AND ANESTHETIZED ALBINO RAT 1

  1977influential reference
• Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids).

  1976cited by this paper
• ENZYMIC AND CEREBRAL METABOLIC EFFECTS OF 2‐DEOXY‐d‐GLUCOSE

  1973cited by this paper
• Phosphate mediation of the Crabtree and Pasteur effects.

  1972cited by this paper
• Localization of the primary metabolic block produced by 2-deoxyglucose.

  1957cited by this paper
• On the origin of cancer cells.

  1956cited by this paper
• [Origin of cancer cells].

  1956cited by this paper

• Estimation of liver standardized uptake value in F18-FDG PET/CT scanning: impact of different malignancies, blood glucose level, body weight normalization, and imaging systems

  2024cites this paper
• OBHS Drives Abnormal Glycometabolis Reprogramming via GLUT1 in Breast Cancer

  2023cites this paper
• Deuterium MRSI characterizations of glucose metabolism in orthotopic pancreatic cancer mouse models

  2021cites this paper
• Heterogeneity of Glucose Transport in Lung Cancer

  2020cites this paper
• Prediction of Necrotic Core and Hypoxic Zone of Multicellular Spheroids in a Microbioreactor with a U-Shaped Barrier

  2018cites this paper
• ATB0,+ transporter-mediated targeting delivery to human lung cancer cells via aspartate-modified docetaxel-loading stealth liposomes.

  2017cites this paper
• A Continuously Infused Microfluidic Radioassay System for the Characterization of Cellular Pharmacokinetics

  2016cites this paper
• Glucose Transporter Regulation in Cancer: A Profile and the Loops.

  2016cites this paper
• Glucosamine-anchored doxorubicin-loaded targeted nano-niosomes: pharmacokinetic, toxicity and pharmacodynamic evaluation

  2016cites this paper
• Modulation of the uptake of critical nutrients by breast cancer cells by lactate: Impact on cell survival, proliferation and migration.

  2016cites this paper
• Real-time Investigation of Underlying Physiology behind PET Tracer Uptake based on Positron Imaging of a Microfluidic Chip and a Window Chamber

  2016cites this paper
• Exploring the quantitative relationship between metabolism and enzymatic phenotype by physiological modeling of glucose metabolism and lactate oxidation in solid tumors

  2015influential citation
• Computational Modeling of Signal Mechanisms for High Resolution Positron Imaging of Tumor Metabolism

  2015cites this paper
• A Reaction-Diffusion Simulation Model of [^{18}F]FDG PET Imaging for the Quantitative Interpretation of Tumor Glucose Metabolism

  2015cites this paper
• Functional characterization and expression of folate receptor-α in T47D human breast cancer cells

  2015cites this paper
• Molecular Mechanisms of Nanoliposomal C6-ceramide-induced Cell Death in Chronic Lymphocytic Leukemia

  2015cites this paper
• ATRA AS A POTENTIAL ANTIMETASTATIC AGENT IN COLORECTAL ADENOCARCINOMA

  2014cites this paper
• Molecular expression and functional activity of vitamin C specific transport system (SVCT2) in human breast cancer cells.

  2014cites this paper
• The influence of cell growth and enzyme activity changes on intracellular metabolite dynamics in AGE1.HN.AAT cells.

  2014cites this paper
• Role of Membrane Transporters in Drug Delivery, Drug Disposition And Drug-Drug Interactions

  2014cites this paper
• Hesperetin impairs glucose uptake and inhibits proliferation of breast cancer cells

  2013cites this paper
• Hyperpolarized 13C NMR studies of glucose metabolism in living breast cancer cell cultures

  2013cites this paper
• Biotin uptake by T47D breast cancer cells: functional and molecular evidence of sodium-dependent multivitamin transporter (SMVT).

  2013cites this paper
• C6-Ceramide Nanoliposomes Target the Warburg Effect in Chronic Lymphocytic Leukemia

  2013cites this paper
• Quantitation of glucose uptake in tumors by dynamic FDG-PET has less glucose bias and lower variability when adjusted for partial saturation of glucose transport

  2012cites this paper
• Natural D‐glucose as a biodegradable MRI contrast agent for detecting cancer

  2012cites this paper
• The power of FDG-PET to detect treatment effects is increased by glucose correction using a Michaelis constant

  2012cites this paper
• Progressive increase of glucose transporter-3 (GLUT-3) expression in estrogen-induced breast carcinogenesis

  2012cites this paper
• Mathematical models of cell cycle progression : applications to breast cancer cell lines.

  2012cites this paper
• Prognostic significance of the standardized uptake value of pre-therapeutic 18F-FDG PET in patients with malignant lymphoma

  2011cites this paper
• Insulin regulates GLUT1‐mediated glucose transport in MG‐63 human osteosarcoma cells

  2011cites this paper
• Glucose Metabolism in Breast Cancer and its Implication in Cancer Therapy

  2011cites this paper
• 17β-Estradiol Augments 18F-FDG Uptake and Glycolysis of T47D Breast Cancer Cells via Membrane-Initiated Rapid PI3K–Akt Activation

  2010cites this paper
• Glucose Transporter-1 as a New Therapeutic Target in Laryngeal Carcinoma

  2010cites this paper
• Kinetics of hyperpolarized 13C1-pyruvate transport and metabolism in living human breast cancer cells

  2009cites this paper
• Regulation of energy metabolism pathways by estrogens and estrogenic chemicals and potential implications in obesity associated with increased exposure to endocrine disruptors.

  2009cites this paper
• Award Number: W81XWH-07-1-0348 TITLE: Development of Anti-GLUT-1 Antibody as a Novel Therapeutic Strategy against Breast Cancer

  2008cites this paper
• Regulation of GLUT3 and glucose uptake by the cAMP signalling pathway in the breast cancer cell line ZR‐75

  2008cites this paper
• Clinical Significance of FDG Single-Photon Emission Computed Tomography: Computed Tomography in the Diagnosis of Head and Neck Cancers and Study of Its Mechanism

  2008cites this paper
• Phosphocholine as a biomarker of breast cancer: Molecular and biochemical studies

  2007cites this paper
• Downregulation of the Expression of GLUT1 Plays a Role in Apoptosis Induced by Sodium Butyrate in HT-29 Cell Line

  2006cites this paper
• Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer

  2005cites this paper
• Naringenin Inhibits Glucose Uptake in MCF-7 Breast Cancer Cells: A Mechanism for Impaired Cellular Proliferation

  2004cites this paper
• Estrogen and progesterone up-regulate glucose transporter expression in ZR-75-1 human breast cancer cells.

  2003cites this paper
• Glycolysis and glucose transporter 1 as markers of response to hormonal therapy in breast cancer

  2003cites this paper
• Evaluation of 2-deoxy-D-glucose as a chemotherapeutic agent: mechanism of cell death

  2002cites this paper
• Glycolysis as a metabolic marker in orthotopic breast cancer, monitored by in vivo (13)C MRS.

  2002cites this paper